A trypsin accessibility assay offers a direct approach for assessing surface display because externally exposed regions of a Bordetella pertussis autotransporter (BrkA) fusion protein are susceptible to proteolytic cleavage, whereas inaccessible or improperly displayed proteins remain protected. Here, we describe a detailed protocol for using a trypsin accessibility assay to characterize surface display of a BrkA fusion protein expressed in Escherichia coli UT5600. The protocol includes controlled trypsin treatment of intact cells, sample preparation for SDS-PAGE, and immunodetection of cleavage products by Western blot using an anti-6xHis antibody. Surface-displayed proteins are expected to remain largely intact, allowing clear discrimination between exposed and inaccessibly fusion proteins. This assay provides an accessible and reproducible strategy for evaluating BrkA-mediated surface presentation of recombinant proteins and may be adapted for characterization of other autotransporter-based display constructs, thus supporting broader application of autotransporter systems in protein engineering and surface display studies.
No takes yet. Share an insight, caveat, or question.
Jonathan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: